Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2023 | Chemotherapy for early metastatic seminoma

Lucia Nappi • 16 Feb 2023
GU Cancers 2023
Genitourinary Cancer Testicular Cancer

Lucia Nappi, MD, University of British Columbia, Vancouver, Canada, discusses the role of chemotherapy in early-stage metastatic seminoma. There is an approximate 98% cure-rate amongst this patient population with standard chemotherapy or radiotherapy. The controversy surrounding treatment is associated with long-term toxicities and whether this can be avoided. Dr Nappi highlights the role miR371 to guide treatment selection following orchiectomy. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lucia Nappi

SWOG S1823: miR-371 as a biomarker for in early-stage testicular cancer
2:11
SWOG S1823: miR-371 as a biomarker for in early-stage testicular cancer
Lucia Nappi • 1 Jun 2026
How can miR371be used to optimize surveillance in testicular cancer?
1:34
How can miR371be used to optimize surveillance in testicular cancer?
Lucia Nappi • 1 Jun 2026
Evaluating microRNA 371a-3p performance in testicular cancer surveillance
2:07
Evaluating microRNA 371a-3p performance in testicular cancer surveillance
Lucia Nappi • 1 Jun 2026
Genomic features of mediastinal germ cell tumors
1:44
Genomic features of mediastinal germ cell tumors
Lucia Nappi • 16 Feb 2023

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals